Bionano raises $18M via convertible debt, retires High Trail Note, warns of going concern

Bionano Genomics, Inc.

Issued $20M principal senior secured convertible debentures (11% interest, due 2026) plus 2.25M shares for $18M gross proceeds.
Used ~$17.6M to redeem High Trail Note (outstanding $15.337M at 115% redemption, plus $2.19M retirement fee); Note cancelled.
Debentures convertible at $2.00/share; Company must maintain $11M blocked account; monthly redemption up to $1M allowed.
Cash runway only into Q4 2024; substantial doubt about going concern exists; board formed strategy committee for alternatives.

item 1.01 item 1.02 item 2.03 item 3.02 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.